Progranulin (PGRN) is a multifunctional protein known to be involved in inflammation. However, the relation between PGRN and atherosclerosis remains elusive. The aim of this study was to define the role of PGRN in the development of atherosclerosis.
Introduction
We previously reported that progranulin (PGRN), which is secreted from human monocyte-derived macrophages, is bound to apolipoprotein A-I (apoA-I), a major component of HDL.
1 PGRN is a multifunctional glycoprotein involved in cellular proliferation, survival, migration, and wound repair. 2 -6 Moreover, some mutations in the PGRN gene have been reported to result in frontotemporal lobar degeneration. 7, 8 PGRN is also known to be involved in inflammation. 4, 5 PGRN, which is thought to be an anti-inflammatory molecule, can be cleaved by proteinases, such as proteinase 3 and neutrophil elastase, into granulin, 3, 9, 10 which is a proinflammatory growth factor. PGRN has been reported to bind directly to TNF receptors and suppress inflammation by disrupting TNF-a signalling. 11, 12 On the other hand, deletion of PGRN has recently been reported to prevent the development of high-fat diet (HFD)-induced insulin resistance in mice, 13 suggesting that PGRN plays a role in the development of atherosclerosis. Although abundant expression of PGRN in vascular smooth muscle cells (SMC) of human carotid endoatherectomy specimens has been previously reported, 14 there is no information available on the direct effect of PGRN expression on atherosclerosis. Therefore, we generated PGRN 2/2 ApoE 2/2 (double knockout, DKO) mice to explore the role of PGRN in atherogenesis. DKO mice that were fed HFD for 12 weeks developed severe atherosclerosis compared with ApoE KO mice fed the same diet, suggesting that PGRN has an atheroprotective role in the development of atherosclerosis.
The increase in atherosclerotic lesions in DKO mice was in part due to the enhanced expression of adhesion molecules, as well as the decreased expression of endothelial nitric oxide synthase (eNOS) in the aortic lesions. Moreover, lack of PGRN leads to accumulate excessive cholesterol in the macrophages and alter HDL-associated proteins. This is the first report showing that the absence of PGRN exacerbates the development of atherosclerosis.
Methods
Detailed materials and methods are available in the Supplementary material online.
Animals
PGRN KO mice, which were generated by Dr. Nishihara and colleagues 15 were obtained from the Riken BioResource Center (Tsukuba, Japan). PGRN KO mice were crossed with ApoE KO mice in a C57BL/6J background (obtained from Jackson Immunoresearch Laboratories, West Grove, PA, USA) to generate PGRN 2/2 ApoE 2/2 (DKO) mice. The genotypes were determined by the PCR performed on tail DNA (see Supplementary material online, Figure S1 ). Mice (4 weeks old) were fed HFD (D12492; Research Diets, New Brunswick, NJ, USA) for 12 weeks, whereas older mice (60 weeks old) were fed HFD for 8 weeks. All mice used in these experiments were housed in a temperature-and humidity-controlled facility with a 12-h light/dark cycle. Mice were anaesthetized with an isoflurane and an intraperitoneal injection of pentobarbital (30 mg/kg body weight). Adequate anaesthesia was ensured by monitoring the respiration rate and absence of a response to a paw pinch. The experimental protocol was approved by the Ethics Review Committee for Animal Experimentation of Osaka University School of Medicine. This study conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication, 8th Edition, 2011).
Cell culture
Human umbilical vein endothelial cells (HUVECs) were purchased from Lonza and were grown in Endothelial Growth Medium-2 Bullet Kit. HUVECs were used within the first six passages. Confluent HUVECs were serum-starved in M-199 phenol red-free medium containing 1% bovine serum albumin (BSA) for 4 h before stimulation. Cells were stimulated with the indicated doses of human recombinant PGRN for 30 min before a 4-h TNF-a (5 ng/mL) challenge.
Histology
The thoracic descending aorta was obtained from autopsied individuals with the informed consent of the families of the deceased. This study conformed to the principles outlined in the Declaration of Helsinki and was approved by the Ethics Review Committee for Animal Experimentation of Osaka University School of Medicine. Immunohistochemical staining was performed on formalin-fixed paraffin sections. PGRN, vascular SMCs, and macrophages were detected with rabbit anti-human PGRN (2.5 mg/mL), mouse antihuman smooth muscle actin (1:50, clone 1A4; DAKO, Glostrup, Denmark), and mouse anti-human CD68 (1:50, clone KP1; DAKO) antibodies, respectively. Immunohistochemical reactions were visualized using an ABC kit (Vector Laboratories, Burlingame, CA, USA) or fluorescencelabelled secondary antibodies (1:200, Alexa Fluor w 488-conjugated goat anti-mouse IgG and 1:200, Alexa Fluor w 594-conjugated goat anti-rabbit IgG antibodies; Life Technologies, Carlsbad, CA, USA). Counter staining for the ABC method was performed with methyl green solution (Sigma-Aldrich, St Louis, MO, USA). Non-immune rabbit IgG (DAKO) at the same concentration as anti-PGRN antibody was applied for a negative control.
Mice were perfused with phosphate-buffered saline (PBS) containing heparin, via the left ventricle under anaesthesia. After separation, the aortic sinus was embedded and frozen in OCT compound (Tissue-Tek w ; Sakura Fine Technical Co., Ltd., Tokyo, Japan). Cryostat sections cut at 10-mm thickness were air-dried for 30 min, and fixed in cold acetone for 10 min. Immunofluorescence staining was performed using the indirect fluorescent antibody method. Briefly, 10% non-immune serum from the host species of a secondary antibody was used to block non-specific staining. PGRN ′ ,6-diamidino-2-phenylindole dilactate (DAPI; 0.2 mg/mL; D9542; Sigma-Aldrich). The sheep control IgG (1:1000; R&D Systems) was used as a negative control. Double immunofluorescence staining for PGRN and macrophages or SMCs was sequentially performed with these procedures. A rat anti-mouse CD31 antibody (1:50, BD Biosciences, Franklin Lakes, NJ, USA) was used for the detection of endothelia. The captured images were processed using Photoshop.
Quantitative analysis of atherosclerotic lesions
After DKO mice and their ApoE KO littermates were fed HFD for 12 weeks, mice were sacrificed and perfused with 4% paraformaldehyde in saline. The entire aorta was dissected and opened longitudinally. After staining with Oil Red O, the aortas were scanned, and the plaque area relative to the total aortic area was quantified using Image J software. Ten micrometre-thick frozen cross sections of the aortic sinus embedded in OCT compound were mounted on slides and stained with Oil Red O. The mean value of the plaque area in the aortic wall per section was calculated.
Quantitative real-time PCR
Total RNA (1 mg) isolated from tissues, macrophages, and HUVEC was primed with 50 pmol of oligo(dT)-20 and reverse-transcribed with SuperScript III (Invitrogen, Carlsbad, CA, USA) for first-strand cDNA synthesis, according to the protocol supplied by the manufacturer. Quantitative realtime PCR was performed using an Opticon 2 system (Bio-Rad Laboratories, Inc., Hercules, CA, USA) according to the protocol provided along with the DyNamo HS SYBR Green quantitative PCR kit (Finnzymes Oy, Vantaa, Finland). The relative gene expression was quantified using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an internal control. Primer sequences are described in Supplementary material online, Tables S1 and S2.
Cellular cholesterol efflux
Mouse peritoneal macrophages were cultured overnight in serum-free Dulbecco's modified Eagle medium (DMEM) containing 1.0 mCi/mL [ 3 H]-cholesterol, and then incubated in DMEM containing 0.1% BSA with HDL (50 mg/mL). Cellular cholesterol efflux was expressed as the percentage of radioactivity of [ 3 H]-cholesterol in the efflux medium relative to the total cell-labelled radioactivity. Radioactivity was determined by liquid scintillation counting, with 0.1% BSA as the background value. HDL-mediated cholesterol efflux was calculated by subtracting the background from the total cellular cholesterol efflux.
Statistical analysis
All data were expressed as mean + SD. Differences among multiple groups were compared by one-way ANOVA followed by a post hoc comparison test with the Bonferroni method. Student's t-test was used to analyse differences between the two groups. A P-value of ,0.05 was considered as statistically significant.
Results

PGRN is highly expressed in macrophages in human atherosclerotic plaques of the aorta
First, to evaluate the role of PGRN in atherosclerosis, we performed immunohistochemical staining of human atherosclerotic plaques of the aorta. Immunohistochemical analysis of human aortas indicated strong expression of PGRN in foam cells of the plaque shoulder ( Figure 1A and B). Double staining for PGRN and CD68 demonstrated that PGRN is co-localized with CD68 to a greater extent ( Figure 1C , E, and G), than with smooth muscle actin ( Figure 1D , F, and H ). These results suggest that PGRN, especially in the macrophages, play a role in atherosclerosis.
3.2 PGRN is highly expressed in the macrophages of atherosclerotic lesions from ApoE KO mice fed HFD First, we confirmed severe atherosclerotic lesions of the aortic root in ApoE KO mice fed HFD for 12 weeks by haematoxylin and eosin (HE) staining. To determine whether PGRN is expressed highly in the atherosclerotic plaques of ApoE KO mice, we performed immunohistochemical analysis. The results show that PGRN is highly expressed in the atherosclerotic plaque of the aortic root in ApoE KO mice. In addition, PGRN was detected in macrophages stained with F4/80, and also co-localized with smooth muscle actin, to a lesser extent (Figure 2A) , indicating that the PGRN in the macrophages play an important role in the development of atherosclerosis. This finding was consistent with the abundant expression of PGRN in foam macrophages in human atherosclerotic plaques. Moreover, we also evaluated PGRN expression in endothelial cells. Although PGRN was in small part co-localized with CD31, we could hardly detect PGRN in CD31 + endothelial cells ( Figure 2B ).
3. Figure 3A) . The mean value of the lipid-stained area in the aortic wall in each section of the DKO mice was much larger, by 3-to 4-fold, compared with that of ApoE KO mice ( Figure 3B ). We also evaluated the atherosclerotic lesions in multiple sections of the aortic sinus in both groups. In concordance with the results obtained with the en face method, lesions in DKO mice were considerably larger than in ApoE KO mice ( Figure 3C and Supplementary material online, Figure S2A ). Quantitative analysis showed that the plaque area in the aortic sinus of DKO mice was significantly larger, by 3-fold ( Figure 3D ). We also performed similar experiments in older mice, and the data showed that older DKO mice exhibited more pronounced atherosclerosis (Supplementary material online, Figure S2B -E). These results suggest that PGRN plays a crucial role in the development of atherosclerosis.
PGRN deficiency exaggerates atherosclerosis in spite of a diminished atherogenic lipid profile
No significant difference was noted in body weight, plasma glucose, and insulin levels between ApoE KO and DKO mice ( Figure 4A-C) . We next Progranulin deficiency worsens atherosclerosis examined the plasma lipid and lipoprotein profile in both groups by HPLC. The total cholesterol concentration was significantly lower in DKO mice than in ApoE KO mice, whereas similar plasma triglyceride levels were observed in both groups ( Figure 4D and F ) . Furthermore, a lower VLDL-cholesterol concentration was detected in DKO mice compared with that in ApoE KO mice ( Figure 4E and G) . Surprisingly, DKO mice exhibited enhanced atherosclerosis despite having an attenuated atherogenic lipid profile. Quantitative PCR analysis of mRNA extracted from the liver tissues of ApoE KO and DKO mice showed that expressions of microsomal triglyceride transfer protein (MTP) mRNA and protein were significantly lower in DKO mice than in ApoE KO mice (Supplementary material online, Figure S3A -C), indicating that the decreased plasma cholesterol levels in DKO mice were partly due to the reduced secretion of cholesterol from the liver.
PGRN deficiency promotes inflammation in the aortas of ApoE KO mice
The atherogenic phenotypes of PGRN deficiency in HFD-fed ApoE KO mice prompted us to investigate the underlying pathogenic mechanisms. The expression of TNF-a, IL-1b, and monocyte chemoattractant protein (MCP)-1 mRNAs were significantly higher in the livers of DKO mice, whereas the expression of IL-6 and IL-10 mRNA were not significantly different between the two groups of mice ( Figure 5A ). The expression levels of inflammatory cytokines and adhesion molecules in the aorta were also analysed. The mRNA levels of TNF-a, but not those of IL-6, IL-1b, and MCP-1, in the aortas were higher in DKO mice than in ApoE KO mice ( Figure 5B ). The expression levels of adhesion molecules, such as intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1, in the aortas were significantly higher in DKO mice than in ApoE KO mice ( Figure 5B ). Next, we use HUVECs in culture to test whether PGRN exerts protective effects on endothelial functions. As expected, PGRN suppressed TNF-a-induced expression of ICAM-1 and VCAM-1 in an approximately dose-dependent manner, indicating that PGRN plays a direct protective role in endothelial cells ( Figure 5C ). Moreover, to evaluate the effect of PGRN deficiency on endothelial function, we examined the expression levels of eNOS protein and its phosphorylated form, p-eNOS, in the aortas of DKO and ApoE KO mice. The protein levels of eNOS and p-eNOS in the aorta were relatively lower in DKO mice than in ApoE KO mice ( Figure 5D ). Taken together, these data indicate that PGRN protects aortic cells from inflammation.
Lack of progranulin leads to accumulate excessive cholesterol in the macrophages and alter HDL-associated proteins
Next, we examined the effect of PGRN on cholesterol homeostasis in macrophages. For this purpose, we analysed the expression of genes involved in the regulation of the intracellular cholesterol content, especially those involved in cholesterol influx and efflux. ATP-binding cassette transporters A1 (ABCA1) and G1 (ABCG1) are known to mediate cholesterol efflux via ApoA-I and HDL, respectively. 16 In DKO mice, ABCG1 mRNA levels in the macrophages were lower and ABCA1 mRNA levels were higher than the corresponding levels in ApoE KO mice, possibly in compensation for the decreased expression of ABCG1 ( Figure 6A ). In contrast, the expression of CD36 and scavenger receptor class A, both of which are known to mediate cholesterol uptake, was higher in the macrophages of DKO mice than in the macrophages of ApoE KO mice ( Figure 6A ). We speculated that increased ABCA1 expression is a secondary effect, a compensatory response to the excessive cholesterol accumulation. Therefore, we tested whether macrophages from DKO mice were more prone to form foam cells compared with macrophages from ApoE KO mice. We Progranulin deficiency worsens atherosclerosis evaluated the uptake of oxidized LDL in bone marrow-derived macrophages from ApoE KO mice and DKO mice. There were approximately twice as many Oil Red O-positive DKO macrophages as there were ApoE KO macrophages ( Figure 6B and C). Macrophages from DKO old mice fed an HFD were also prone to accumulate more excessive cholesterol compared with macrophages from ApoE KO old mice (Supplementary material online, Figure S2F and G). It is conceivable that the elevated ABCA1 mRNA levels in the macrophages of DKO mice were not a direct result of the loss of PGRN, but rather a compensatory response to the excessive cholesterol accumulation. Taken together, these data suggest that PGRN deletion leads to accumulate excessive cholesterol in the macrophages and may thus accelerate atherogenesis. Inflammation has been shown to change the composition of HDL particles, altering their anti-atherogenic properties to pro-atherogenic properties 17, 18 Therefore, we investigated the effect of PGRN deficiency on the composition of HDL particles. The proportion of ApoA-I, which is the major apolipoprotein in HDL with an antiatherogenic role, is comparable in HDL particles of DKO and ApoE KO mice. However, the proportion of platelet-activating factor acetyl hydrolase (PAF-AH), which inactivates PAF and prevents LDL oxidation by hydrolysing oxidized phospholipids is lower in HDL particles of DKO mice than in ApoE KO mice ( Figure 6D and E). Moreover, serum amyloid A (SAA1), the expression of which is enhanced during inflammation, is markedly increased in HDL particles of DKO mice ( Figure 6D and E) . These results suggest that the absence of PGRN might alter HDL function. Finally, we assessed the effect of PGRN deficiency on the capacity of HDL to take up cholesterol from macrophages. There were no significant differences in cholesterol efflux between HDLs derived from ApoE KO and DKO mice ( Figure 6F ).
Discussion
The main findings of the present study are as follows: (i) atherosclerotic lesions in the aortas of PGRN KO mice in a background of ApoE KO (DKO mice) were more pronounced than those in ApoE KO mice.
(ii) The enhanced susceptibility of DKO mice to atherosclerosis, irrespective of the lower plasma cholesterol levels than in ApoE KO mice, might be due to one or more of the following reasons: (a) enhanced inflammatory status, (b) enhanced conversion of macrophages to foam cells, partly through lower expression of genes related to cholesterol efflux It has been previously reported that serum PGRN levels were higher in individuals with type 2 diabetes mellitus and in obese subjects with visceral fat accumulation compared with control subjects 19 -21 Moreover, serum PGRN concentrations also correlated with body mass index, serum HbA1c, total cholesterol, and high-sensitive C-reactive protein in obese subjects. These reports suggest that high circulating levels of PGRN can induce systemic or local inflammation. HFD-fed PGRN KO mice have recently been reported to be characterized by low insulin resistance, possibly through the suppression of IL-6 production, and are less prone to develop obesity compared with WT mice, indicating that PGRN induces insulin resistance. 14 On the other hand, in addition to the previous reports suggesting that PGRN exerts an anti-inflammatory effect, 10, 11 Yin et al. 22 demonstrated that the macrophages of PGRN KO mice secrete lower levels of the anti-inflammatory cytokine IL-10 and higher levels of proinflammatory cytokines such as IL-6 and TNF-a, 22 suggesting that these properties account for systemic or local inflammation in DKO mice. As a matter of fact, high serum IL-6 levels have been reported in patients with frontotemporal lobar degeneration (FTLD) and PGRN mutation compared with FTLD patients without PGRN mutation and control subjects. 23 As described above, the effect of PGRN on the development of atherosclerosis has not been elucidated thus far; however, in this study, for the first time, we showed that deletion of PGRN accelerates the development of atherosclerosis in mice in an ApoE KO background. Kojima et al. 14 reported abundant expression of PGRN in vascular SMCs of human carotid endoatherectomy specimens rather than in macrophages. However, immunohistochemical analysis of human aortas showed strong expression of PGRN in foam cells of the plaque shoulder. Double staining for PGRN and CD68 revealed that the cells were macrophages rather than SMCs. Expression levels of PGRN in some stress conditions such as hypoxia, 24, 25 acidosis, 25 age, 20 as well as in the neurogenerative brain 26 have been reported to be increased, suggesting that enhanced expression of PGRN was a result of a compensatory response, as discussed by Yin et al.
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Although PGRN 2/2 apoE 2/2 mice had low serum levels of total cholesterol, larger atherogenic areas were found in their aortas compared Progranulin deficiency worsens atherosclerosis with their littermates. The decreased plasma cholesterol levels were partly due to the decreased expression of microsomal triglyceride transfer protein (MTP) in the liver of DKO mice; however, details of the underlying mechanism require further examination. Our findings indicate that these atherogenic lesions are accounted for by the high levels of proinflammatory cytokines, enhanced expression of ICAM-1 and VCAM-1, and low levels of eNOS and its phosphorylated form in the aortas of DKO mice, compared with their littermates. It must be mentioned that these results might reflect the changed cell composition of the aortas between the two groups of mice. This might be a limitation of these experiments, which is also true for the qPCR experiments in the macrophages ( Figure 6A) . The phenotypic changes in macrophages of DKO mice, i.e. increased secretion of proinflammatory cytokines, could be also involved in atherogenesis. 22 PGRN has recently been reported to bind directly to TNF receptors (TNFRs), resulting in dysregulation of the TNF-a-TNFR interaction and inhibition of TNF-a-activated intracellular signalling. 7 The enhanced atherosclerosis in HFD-fed DKO mice may involve enhanced TNF-a-activated intracellular signalling.
The results of the present study also showed that lack of PGRN seems to promote transformation of macrophages to foam cells. Although we showed that the mRNA levels of genes related to cholesterol influx and efflux were altered, we intend to address the underlying mechanism in our future studies.
Acute and chronic inflammation has recently shown to change antiatherogenic HDL to pro-atherogenic HDL by altering the composition of HDL particles. Therefore, both the function of HDL, through its associated proteins, as well as the quantity of plasma HDL have been shown to be important. PGRN deficiency altered the proportions of HDL-associated proteins, despite a lack of change in plasma HDL-C levels. Levels of ApoA-I, a major HDL component, in HDL particles were not different in the DKO and ApoE KO mice. SAA1 is an HDL-associated protein, and its expression is known to increase, especially during inflammation, such that it becomes the major protein in HDL. 27, 28 In the mouse, SAA1.1 is a major isoform of SAA and is more acutely and dynamically changed in response to inflammation. 28 We found that SAA1.1 protein levels in HDL particles of DKO mice were much higher than that of ApoE KO mice. In addition, protein levels of PAF-AH, a major HDL-associated anti-oxidant molecule, were significantly decreased in DKO mice compared with those in ApoE KO mice. These data suggest that the susceptibility of DKO mice to atherosclerosis is, in part, due to the decreased anti-oxidant capacity of HDL particles. Although PGRN has various diverse atheroprotective effects, we cannot determine which anti-atherogenic effect is predominant.
In conclusion, the present study demonstrated that PGRN seems to be associated with the pathophysiology of atherogenesis through various mechanisms, including suppression of inflammation and maintenance of intracellular cholesterol homeostasis. PGRN has also been known to interact with extracellular, transmembrane, intracellular, and nuclear proteins. 6, 12 Therefore, PGRN could be a promising pharmacological target molecule in the treatment of inflammatory diseases. However, the physiological significance of PGRN warrants further study, especially with respect to its role in the development of atherosclerosis.
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